Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Late Phase Randomized Open-Label Multi Cohort Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies

NCT07174453 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT07174453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07174453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Late Phase Randomized Open-Label Multi Cohort Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies
Lead sponsor
University of Kansas Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
October 7, 2025
Completion date
October 1, 2029
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor malignancies